Renal Cancer - Results from #5340

Pretreatment Serum Prealbumin as an Independent Prognostic Indicator in Patients With Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors as First-Line Target Therapy February 16, 2017

Clinical Pharmacokinetics and Pharmacodynamics of Pazopanib: Towards Optimized Dosing February 15, 2017

A prospective, multicenter analysis of pseudocapsule characteristics: Do all stages of renal cell carcinoma have complete pseudocapsules? February 15, 2017

Preoperative albumin to globulin ratio predicts survival in clear cell renal cell carcinoma patients February 15, 2017

Identification of patient-specific and tumor-shared T cell receptor sequences in renal cell carcinoma patients February 15, 2017

The current management of renal cell carcinoma February 15, 2017

Utility of prospective pathologic evaluation to inform clinical genetic testing for hereditary leiomyomatosis and renal cell carcinoma February 15, 2017

Expression pattern of immune checkpoint-associated molecules in radical nephrectomy specimens as a prognosticator in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors February 15, 2017

Functional KRAS mutations and a potential role for PI3K/AKT activation in Wilms Tumors February 13, 2017

Stereotactic Ablative Body Radiotherapy for Inoperable Primary Kidney Cancer: A Prospective Clinical Trial February 13, 2017

Should Small Renal Masses Be Biopsied? February 13, 2017

Real-World Survival Outcomes and Prognostic Factors Among Patients Receiving First Targeted Therapy for Advanced Renal Cell Carcinoma: A SEER-Medicare Database Analysis February 9, 2017

A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer February 9, 2017

Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study February 8, 2017

Managing metastatic renal cell carcinoma-challenges, pitfalls, and outcomes in the real world February 8, 2017

Targeted Therapy for Metastatic Renal Cell Carcinoma February 8, 2017

Incidental renal tumors in cancer survivors: Minimally invasive management by image-guided thermal ablation February 6, 2017

Activity of chemokines in prostate and renal tumors and their potential role as future therapeutic targets February 6, 2017

Open partial nephrectomy for entirely intraparenchymal tumors: a matched case-control study of oncologic outcome and complication rate February 3, 2017

The effect of TMEFF2 methylation on the tumor stage and survival outcome of clear cell renal cell carcinoma February 3, 2017

Page 268 of 456